Collaboration to advance Global Drug Discovery Infrastructure

Drug discovery software developer Optibrium has announced a collaboration with US-based MSD which has adopted the Cambridge, UK company's StarDrop™ software as a central component of their cheminformatics infrastructure. The partnership will also include the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.

Dr Matthew Segall, Optibrium’s CEO, commented, “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”

MSD is a tradename of Merck & Co Inc, Kenilworth NJ

Further information www.online